Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.
about
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesRisk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data.Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.ErbB signaling in cardiac development and disease.Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.
P2860
Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@ast
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@en
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@nl
type
label
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@ast
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@en
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@nl
prefLabel
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@ast
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@en
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@nl
P2093
P2860
P1476
Thiazolidinediones and cardiov ...... ther oral antidiabetic agents.
@en
P2093
Fadia T Shaya
Kyongsei Sohn
Matthew R Weir
Zhiqiang Lu
P2860
P304
P577
2009-09-01T00:00:00Z